世界の核酸増幅検査市場(2023-2030):種類別(PCR、INAAT)、用途別(感染症検査、がん検査)、エンドユーザー別、地域別

【英語タイトル】Nucleic Acid Amplification Testing Market Size, Share & Trends Analysis Report By Type (PCR, INAAT), By Application (Infectious Disease Testing, Oncology Testing), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料(GRV23NOV177)・商品コード:GRV23NOV177
・発行会社(調査会社):Grand View Research
・発行日:2023年9月
・ページ数:120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:臨床診断
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,360,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

核酸増幅検査市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の核酸増幅検査市場規模は、2023年から2030年にかけて12.2%のCAGRを記録し、2030年までに192億米ドルに達する見込みです。慢性疾患や感染症の早期発見に関する意識の高まりや、PCR技術の新たな技術的進歩が、市場成長を大きく促進すると予想される要因です。さらに、インフルエンザ、肝炎、性感染症などの感染症の世界的な流行増加は、核酸増幅検査の需要を増加させ、市場成長にプラスの影響を与えると予測されています。

核酸増幅検査は、癌のような生命を脅かす病態を含む様々な病態の診断に応用できるため、近年多額の投資が行われています。例えば、セファイド社のGene Xpert技術の開発には、米国国立衛生研究所からの5,600万米ドル以上の助成金と、その他の米国政府部門からの約7,300万米ドルを含む、総額2億5,200万米ドル以上の公的投資が行われました。

さらに、核酸増幅検査の高い効率性と正確性により、培養ベースの同定などの従来の診断オプションよりもこの技術が好まれるようになっています。これらの特性が核酸増幅検査技術の成長を後押ししています。

COVID-19は、SARS-CoV-2ウイルスの検出のために、核酸増幅検査を含む迅速で正確な検査方法に対する需要を高めています。この市場に関与する主要企業は、迅速かつポイント・オブ・ケア検査に対する高い需要に対応するため、等温核酸増幅技術に基づく検査などの新製品を開発しました。

例えば、2020年3月、アボット・ラボラトリーズは、5分以内に陽性、13分以内に陰性の結果が得られるアボットID NOW COVID-19検査の緊急使用承認(EUA)を取得しました。パンデミックに後押しされたこのような戦略的イニシアチブは、近い将来の市場成長を押し上げると予想されます。

核酸増幅検査市場レポートハイライト

- ポリメラーゼ連鎖反応(PCR)検査が2022年に66.7%の最大シェアを獲得しました。

- アプリケーション別では、感染症が2022年に46.4%の最大シェアを占めました。感染症の世界的な流行の高まりと、核酸増幅技術によって提供される効率的な代替検査が、このセグメントを牽引しています。

- 北米は、2022年に37.1%の最大シェアを占めました。この地域には、確立された医療部門と、Abbott Laboratories; Illumina, Inc; Bio-Rad Laboratories, Incなどの主要プレーヤーが存在するためです。

- 医療投資の増加、早期疾患診断のための核酸増幅検査の採用増加により、2022年の市場シェアは41.9%で、中央検査室および標準検査室の最終用途セグメントが市場を独占しました。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 世界の核酸増幅検査市場:タイプ別予測・動向分析
第5章. 世界の核酸増幅検査市場:用途別予測・動向分析
第6章. 世界の核酸増幅検査市場:最終用途別予測・動向分析
第7章. 世界の核酸増幅検査市場:地域別予測・動向分析
第8章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Nucleic Acid Amplification Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Nucleic Acid Amplification Testing Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Nucleic Acid Amplification Testing: Type Estimates & Trend Analysis
4.1. Nucleic Acid Amplification Testing Market: Key Takeaways
4.2. Nucleic Acid Amplification Testing Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Polymerase Chain Reaction (PCR) Tests
4.3.1. Polymerase chain reaction (PCR) tests market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
4.4.1. Isothermal nucleic acid amplification technology (INAAT) tests market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Ligase Chain Reaction (LCR) Tests
4.5.1. Ligase Chain Reaction (LCR) Tests market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Nucleic Acid Amplification Testing: Application Estimates & Trend Analysis
5.1. Nucleic Acid Amplification Testing Market: Key Takeaways
5.2. Nucleic Acid Amplification Testing Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Infectious Disease Testing
5.3.1. Infectious disease testing market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.2. Covid-19 Testing
5.3.2.1. Covid-19 testing market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.3. Mosquito Borne Disease Testing
5.3.3.1. Mosquito borne disease testing market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.4. Influenza Testing
5.3.4.1. Influenza testing market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.5. Sexually Transmitted Infectious Testing
5.3.5.1. Sexually transmitted infectious testing market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.6. Hepatitis Testing
5.3.6.1. Hepatitis testing market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.7. Tuberculosis Testing
5.3.7.1. Tuberculosis testing market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.8. Others
5.3.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Oncology Testing
5.4.1. Oncology testing market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Genetic & Mitochondrial Disease Testing
5.5.1. Genetic & mitochondrial disease testing market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Nucleic Acid Amplification Testing: End Use Estimates & Trend Analysis
6.1. Nucleic Acid Amplification Testing Market: Key Takeaways
6.2. Nucleic Acid Amplification Testing Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Central and Reference Laboratories
6.4.1. Central and reference Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Others
6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Nucleic Acid Amplification Testing Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Nucleic Acid Amplification Testing Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. F. Hoffmann-La Roche Ltd
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Becton, Dickinson and Company
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Danaher Corporation
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Abbott Laboratories
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Illumina, Inc.
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Siemens Healthineers
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. bioMérieux SA
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Novartis AG
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Bio-Rad Laboratories, Inc.
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Seegene Inc.
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 3 North America nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 4 North America nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 5 North America nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 7 U.S. nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 10 Canada nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 11 Canada nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 12 Europe nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 13 Europe nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 14 Europe nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
Table 16 Germany nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 17 Germany nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 18 Germany nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 19 UK nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 20 UK nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 21 UK nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 22 France nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 23 France nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 24 France nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 25 Italy nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 26 Italy nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 27 Italy nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 28 Spain nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 29 Spain nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 30 Spain nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 31 Denmark nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 32 Denmark nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 33 Denmark nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 34 Sweden nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 35 Sweden nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 36 Sweden nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 37 Norway nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 38 Norway nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 39 Norway nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 41 Asia Pacific nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 42 Asia Pacific nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
Table 44 Japan nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 45 Japan nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 46 Japan nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 47 China nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 48 China nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 49 China nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 50 India nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 51 India nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 52 India nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 53 Australia nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 54 Australia nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 55 Australia nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 56 Thailand nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 57 Thailand nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 58 Thailand nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 59 South Korea nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 60 South Korea nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 61 South Korea nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 62 Latin America nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 63 Latin America nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 64 Latin America nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 65 Latin America nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 67 Brazil nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 68 Brazil nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 69 Mexico nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 70 Mexico nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 71 Mexico nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 72 Argentina nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 73 Argentina nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 74 Argentina nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 80 South Africa nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 81 South Africa nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 85 UAE nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 86 UAE nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 87 UAE nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 88 Kuwait nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 89 Kuwait nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 90 Kuwait nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Nucleic acid amplification testing: Market outlook
Fig. 9 Nucleic acid amplification testing: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Nucleic acid amplification testing market driver impact
Fig. 15 Nucleic acid amplification testing market restraint impact
Fig. 16 Nucleic acid amplification testing market strategic initiatives analysis
Fig. 17 Nucleic acid amplification testing market: Type movement analysis
Fig. 18 Nucleic acid amplification testing market: Type outlook and key takeaways
Fig. 19 Polymerase chain reaction (PCR) tests market estimates and forecasts, 2018 - 2030
Fig. 20 Isothermal nucleic acid amplification technology (INAAT) tests market estimates and forecasts, 2018 - 2030
Fig. 21 Ligase chain reaction (LCR) tests market estimates and forecasts, 2018 - 2030
Fig. 22 Nucleic acid amplification testing market: Application movement analysis
Fig. 23 Nucleic acid amplification testing market: Application outlook and key takeaways
Fig. 24 Infectious disease testing market estimates and forecasts, 2018 - 2030
Fig. 25 Covid-19 testing market estimates and forecasts, 2018 - 2030
Fig. 26 Mosquito borne disease testing market estimates and forecasts, 2018 - 2030
Fig. 27 Influenza testing market estimates and forecasts, 2018 - 2030
Fig. 28 Sexually transmitted infection testing market estimates and forecasts, 2018 - 2030
Fig. 29 Hepatitis testing market estimates and forecasts, 2018 - 2030
Fig. 30 Tuberculosis testing market estimates and forecasts, 2018 - 2030
Fig. 31 Others testing market estimates and forecasts, 2018 - 2030
Fig. 32 Oncology testing market estimates and forecasts, 2018 - 2030
Fig. 33 Genetic & mitochondrial disease testing market estimates and forecasts, 2018 - 2030
Fig. 34 Others testing market estimates and forecasts, 2018 - 2030
Fig. 35 Nucleic acid amplification testing market: End-use movement analysis
Fig. 36 Nucleic acid amplification testing market: End-use outlook and key takeaways
Fig. 37 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 38 Central and reference laboratories market estimates and forecasts, 2018 - 2030
Fig. 39 Others market estimates and forecasts, 2018 - 2030
Fig. 40 Global nucleic acid amplification testing market: Regional movement analysis
Fig. 41 Global nucleic acid amplification testing market: Regional outlook and key takeaways
Fig. 42 North America market estimates and forecasts, 2018 - 2030
Fig. 43 U.S. market estimates and forecasts, 2018 - 2030
Fig. 44 Canada market estimates and forecasts, 2018 - 2030
Fig. 45 Europe market estimates and forecasts, 2018 - 2030
Fig. 46 UK market estimates and forecasts, 2018 - 2030
Fig. 47 Germany market estimates and forecasts, 2018 - 2030
Fig. 48 France market estimates and forecasts, 2018 - 2030
Fig. 49 Italy market estimates and forecasts, 2018 - 2030
Fig. 50 Spain market estimates and forecasts, 2018 - 2030
Fig. 51 Denmark market estimates and forecasts, 2018 - 2030
Fig. 52 Sweden market estimates and forecasts, 2018 - 2030
Fig. 53 Norway market estimates and forecasts, 2018 - 2030
Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 55 Japan market estimates and forecasts, 2018 - 2030
Fig. 56 China market estimates and forecasts, 2018 - 2030
Fig. 57 India market estimates and forecasts, 2018 - 2030
Fig. 58 Australia market estimates and forecasts, 2018 - 2030
Fig. 59 Thailand market estimates and forecasts, 2018 - 2030
Fig. 60 South Korea market estimates and forecasts, 2018 - 2030
Fig. 61 Latin America market estimates and forecasts, 2018 - 2030
Fig. 62 Brazil market estimates and forecasts, 2018 - 2030
Fig. 63 Mexico market estimates and forecasts, 2018 - 2030
Fig. 64 Argentina market estimates and forecasts, 2018 - 2030
Fig. 65 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 66 South Africa market estimates and forecasts, 2018 - 2030
Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 68 UAE market estimates and forecasts, 2018 - 2030
Fig. 69 Kuwait market estimates and forecasts, 2018 - 2030

★調査レポート[世界の核酸増幅検査市場(2023-2030):種類別(PCR、INAAT)、用途別(感染症検査、がん検査)、エンドユーザー別、地域別] (コード:GRV23NOV177)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の核酸増幅検査市場(2023-2030):種類別(PCR、INAAT)、用途別(感染症検査、がん検査)、エンドユーザー別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆